Moving repurposed drugs into clinical practice requires rigorous testing to confirm their efficacy and safety in cancer patients. Early-phase trials often focus on dose-finding and initial signs of anti-tumor activity, followed by larger studies comparing them to existing standards of care. Due to their prior approval, the toxicity profiles are generally known, but specific side effec... https://www.beatcancerfoundation.org/